|
TMEM30A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.56610000000046E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.435690E-02 |
| Normal-vs-Stage2 |
1.386140E-02 |
| Normal-vs-Stage3 |
1.60599999998734E-06 |
| Normal-vs-Stage4 |
9.32790000796047E-09 |
| Stage1-vs-Stage2 |
2.804600E-01 |
| Stage1-vs-Stage3 |
1.400430E-03 |
| Stage1-vs-Stage4 |
2.06960000004308E-06 |
| Stage2-vs-Stage3 |
4.950400E-01 |
| Stage2-vs-Stage4 |
1.523560E-01 |
| Stage3-vs-Stage4 |
2.196400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.404830E-04 |
| Normal-vs-AfricanAmerican |
1.219400E-03 |
| Normal-vs-Asian |
2.056600E-01 |
| Caucasian-vs-AfricanAmerican |
7.005000E-01 |
| Caucasian-vs-Asian |
9.093800E-01 |
| AfricanAmerican-vs-Asian |
7.845600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.040810E-04 |
| Normal-vs-Female |
3.763100E-04 |
| Male-vs-Female |
5.741200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.993950E-02 |
| Normal-vs-Age(41-60Yrs) |
2.078300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.40929999999473E-05 |
| Normal-vs-Age(81-100Yrs) |
5.819200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.405400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.357000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.212600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.317400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.478640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.155600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.460000E-01 |
| Normal-vs-Grade 2 |
3.190000E-02 |
| Normal-vs-Grade 3 |
1.70269999988371E-07 |
| Normal-vs-Grade 4 |
4.37049999524319E-08 |
| Grade 1-vs-Grade 2 |
8.428400E-02 |
| Grade 1-vs-Grade 3 |
1.97240999999515E-05 |
| Grade 1-vs-Grade 4 |
3.56759999999845E-05 |
| Grade 2-vs-Grade 3 |
7.57869999999938E-05 |
| Grade 2-vs-Grade 4 |
3.50500000000364E-05 |
| Grade 3-vs-Grade 4 |
1.820980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.676500E-02 |
| Normal-vs-ccB subtype |
8.382200E-04 |
| ccA subtype-vs-ccB subtype |
1.050650E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.425400E-04 |
| Normal-vs-N1 |
7.017700E-03 |
| N0-vs-N1 |
3.275600E-01 |
|
|
